Maharishi Ayurveda Products & Health Supplements
Showing: 1-24 of 40
Kasni Kanth Sudha Tablets - Maharishi Ayurveda
No reviews
Maharishi Ayurveda
Regular price
Rs. 45.00
Amlant Tablets - Maharishi Ayurveda (6 Tablets)
No reviews
Maharishi Ayurveda
Regular price
Rs. 33.00
Energol MA Tablets - Maharishi Ayurveda (20 Tablets)
No reviews
Maharishi Ayurveda
Regular price
Rs. 440.00
Leucomap Capsules - Maharishi Ayurveda (10 Capsules)
1 review
Maharishi Ayurveda
Regular price
Rs. 65.00
AyurDefence - Maharishi Ayurveda (10 Tablets)
No reviews
Maharishi Ayurveda
Regular price
Rs. 135.00
Authentic Chyavanprash - 500GM - Maharishi Ayurveda
No reviews
Maharishi Ayurveda
Regular price
Rs. 400.00
Asthomap Tablets - Maharishi Ayurveda (60 Tablets)
No reviews
Maharishi Ayurveda
Regular price
Rs. 180.00
Livomap Tablets - Maharishi Ayurveda (10 Tablets)
No reviews
Maharishi Ayurveda
Regular price
Rs. 50.00
Filter By Type
Filter By Brands
Filter By Ailments
Popular Products
నీలిభ్రింగాడి తైలామ్ - 200 ఎంఎల్- కొట్టక్కల్
39 reviews
Kottakkal Arya Vaidya Sala
Rs. 230.00
Regular price
Rs. 690.00
కుంకుమాది తైలం (కుంకుమాది తైలం) - 10 మి.లీ
98 reviews
Kottakkal Arya Vaidya Sala
Rs. 480.00
Regular price
Rs. 505.00
నీలిభ్రింగాడి కేరా (కొబ్బరి నూనె) తైలామ్ - 200 ఎంఎల్- కొట్టక్కల్
87 reviews
Kottakkal Arya Vaidya Sala
Rs. 230.00
Regular price
Rs. 690.00
నీలిభ్రింగాడి తైలామ్ - 200 ఎంఎల్- కొట్టక్కల్
39 reviews
Kottakkal Arya Vaidya Sala
Rs. 230.00
Regular price
Rs. 690.00
కుంకుమాది తైలం (కుంకుమాది తైలం) - 10 మి.లీ
98 reviews
Kottakkal Arya Vaidya Sala
Rs. 480.00
Regular price
Rs. 505.00
Warning Information
Incompliance with Drug and Cosmetic Act and Rules, We don't process requests for Schedule X and other habit forming drugs.For Schedule H and H1 drugs you need to upload a valid prescription from a registered medical practitioner.
Ayurkart is available only to persons who can form a legally binding contract under the Indian Contract Act, 1872. If you are a minor i.e. under the age of 18 years, you may use only with the guidance of a parent or guardian.
